{"id":52701,"date":"2023-01-09T17:02:06","date_gmt":"2023-01-09T16:02:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/europe-compounding-pharmacies-market-report-2023-sector-to-grow-by-8-25-annually-through-2028-researchandmarkets-com\/"},"modified":"2023-01-09T17:02:06","modified_gmt":"2023-01-09T16:02:06","slug":"europe-compounding-pharmacies-market-report-2023-sector-to-grow-by-8-25-annually-through-2028-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/europe-compounding-pharmacies-market-report-2023-sector-to-grow-by-8-25-annually-through-2028-researchandmarkets-com\/","title":{"rendered":"Europe Compounding Pharmacies Market Report 2023: Sector to Grow by 8.25% Annually Through 2028 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Europe Compounding Pharmacies Market: Analysis By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Others), By End Users, By Type, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe European Compounding Pharmacies Market is projected to display significant growth represented by a CAGR of 8.25% during 2023-2028. The European Compounding Pharmacies Market was valued at USD 3314.80 Million in the year 2021 with Italy holding the largest market share.\n<\/p>\n

\nIn terms of segments, the availability of a diverse range of compounded formulas for dermatological purposes will drive segment expansion. Patients who are allergic to commercial pharmaceuticals might benefit from dermatology customised treatments.\n<\/p>\n

\nThe European Compounding Pharmacies market is a consolidated market. The major players in the market like Athenex, Baxter International, Fagron, Grifols, Capsa Healthcare, Nephron Pharmaceuticals, B. Braun, Fresenius, McKesson and Omnicell have a large geographical presence and a highly diversified product portfolio. These players focus on R&D, a large product portfolio, a wide geographical presence and an aggressive acquisition strategy.\n<\/p>\n

\nItaly is holding the largest market share and is growing at the fastest rate during the forecast period, owing to the rising prevalence of therapeutic areas as well as the widespread use of pain management in developed countries like the United Kingdom and Germany.\n<\/p>\n

\nThe United Kingdom Compounding Pharmacies market has witnessed growth in recent years due to increased investments and offtake agreements among new companies to cope with new market strategies.\n<\/p>\n

\nFrance is a lucrative market because of the presence of several compounding pharmacies, high adoption among people, and scarcity of many drugs, which are key factors for market growth.\n<\/p>\n

\nScope of the Report<\/strong>\n<\/p>\n